Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2013-07-04 18:54:58 UTC
Update Date2019-07-23 07:14:56 UTC
HMDB IDHMDB0060720
Secondary Accession Numbers
  • HMDB60720
Metabolite Identification
Common Name2-Hydroxynevirapine glucuronide
DescriptionN,O-Didesmethylvenlafaxine glucuronide belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Venlafaxine is a bicyclic antidepressant and is usually categorized as a serotonin-norepinephrine reuptake inhibitor (SNRI), but it has been referred to as a serotonin-norepinephrine-dopamine reuptake inhibitor. N,O-Didesmethylvenlafaxine glucuronide is a very strong basic compound (based on its pKa). In humans, N,O-didesmethylvenlafaxine glucuronide is involved in venlafaxine metabolism pathway. It works by blocking the transporter reuptake proteins for key neurotransmitters affecting mood, thereby leaving more active neurotransmitters in the synapse. N,O-Didesmethylvenlafaxine glucuronide is a metabolite of venlafaxine (brand name: Effexor or Efexor).
Structure
Data?1563866096
Synonyms
ValueSource
N,O-Didesvenlafaxine glucuronideHMDB
N-Desmethyldesvenlafaxine glucuronideHMDB
Chemical FormulaC21H22N4O8
Average Molecular Weight458.4214
Monoisotopic Molecular Weight458.1437637
IUPAC Name(2S,3S,4S,5R,6S)-6-({2-cyclopropyl-10-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-5-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
Traditional Name(2S,3S,4S,5R,6S)-6-({2-cyclopropyl-10-hydroxy-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-5-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
CAS Registry NumberNot Available
SMILES
CC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1
InChI Identifier
InChI=1S/C21H22N4O8/c1-8-7-11(32-21-15(28)13(26)14(27)16(33-21)20(30)31)23-18-12(8)24-19(29)10-3-2-6-22-17(10)25(18)9-4-5-9/h2-3,6-7,9,13-16,21,26-28H,4-5H2,1H3,(H,24,29)(H,30,31)/t13-,14-,15+,16-,21+/m0/s1
InChI KeyRNMZKTLILDCQOC-KUSYAZKWSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct ParentPhenolic glycosides
Alternative Parents
Substituents
  • Phenolic glycoside
  • Fatty acyl glycoside of mono- or disaccharide
  • Fatty acyl glycoside
  • 1-o-glucuronide
  • O-glucuronide
  • Glucuronic acid or derivatives
  • Alkyl glycoside
  • O-glycosyl compound
  • Phenoxy compound
  • Phenol ether
  • Beta-hydroxy acid
  • Aralkylamine
  • Cyclohexanol
  • Hydroxy acid
  • Monosaccharide
  • Monocyclic benzene moiety
  • Fatty acyl
  • Oxane
  • Benzenoid
  • Pyran
  • Cyclic alcohol
  • 1,3-aminoalcohol
  • Tertiary alcohol
  • Amino acid
  • Amino acid or derivatives
  • Secondary alcohol
  • Acetal
  • Oxacycle
  • Carboxylic acid derivative
  • Carboxylic acid
  • Organoheterocyclic compound
  • Secondary amine
  • Secondary aliphatic amine
  • Polyol
  • Monocarboxylic acid or derivatives
  • Carbonyl group
  • Alcohol
  • Organopnictogen compound
  • Amine
  • Organic oxide
  • Hydrocarbon derivative
  • Organonitrogen compound
  • Organic nitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
Process
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility1.39 g/LALOGPS
logP-0.08ALOGPS
logP0.43ChemAxon
logS-2.5ALOGPS
pKa (Strongest Acidic)2.74ChemAxon
pKa (Strongest Basic)3.7ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count12ChemAxon
Hydrogen Donor Count5ChemAxon
Polar Surface Area178.06 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity112.54 m³·mol⁻¹ChemAxon
Polarizability44.93 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+206.36831661259
DarkChem[M-H]-200.00931661259
DeepCCS[M+H]+197.58330932474
DeepCCS[M-H]-195.75830932474
DeepCCS[M-2H]-229.00930932474
DeepCCS[M+Na]+203.18930932474
AllCCS[M+H]+204.732859911
AllCCS[M+H-H2O]+202.632859911
AllCCS[M+NH4]+206.532859911
AllCCS[M+Na]+207.132859911
AllCCS[M-H]-197.832859911
AllCCS[M+Na-2H]-198.032859911
AllCCS[M+HCOO]-198.332859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
2-Hydroxynevirapine glucuronideCC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC14685.2Standard polar33892256
2-Hydroxynevirapine glucuronideCC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC13532.9Standard non polar33892256
2-Hydroxynevirapine glucuronideCC1=CC(O[C@@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC13858.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
2-Hydroxynevirapine glucuronide,1TMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13901.8Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13896.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13895.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13875.9Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13805.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13812.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #10CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13735.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13775.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13776.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13730.7Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13774.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #6CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13780.6Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #7CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13729.7Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #8CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13785.9Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TMS,isomer #9CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13728.8Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13747.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #10CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13702.9Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13734.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13716.9Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13725.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13697.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #6CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13697.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #7CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13732.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #8CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13685.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TMS,isomer #9CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13698.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,4TMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC13725.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,4TMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13690.8Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,4TMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13688.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,4TMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13687.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,4TMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13682.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,5TMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)=NC2=C1N=C(O[Si](C)(C)C)C1=CC=CN=C1N2C1CC13705.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TBDMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14094.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TBDMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14092.6Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TBDMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14089.7Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TBDMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14111.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,1TBDMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC13999.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14144.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #10CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14052.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14093.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14096.6Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14042.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14106.8Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #6CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14100.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #7CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14034.5Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #8CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14128.4Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,2TBDMS,isomer #9CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14038.7Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #1CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14176.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #10CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14127.6Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #2CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14177.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #3CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14130.2Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #4CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14160.8Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #5CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14091.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #6CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14093.3Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #7CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC14167.1Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #8CC1=CC(O[C@@H]2O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14097.9Semi standard non polar33892256
2-Hydroxynevirapine glucuronide,3TBDMS,isomer #9CC1=CC(O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)=NC2=C1N=C(O[Si](C)(C)C(C)(C)C)C1=CC=CN=C1N2C1CC14097.3Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 2-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, Positivesplash10-000f-9206300000-a731eb8b28fd64f65f0f2017-09-20Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-Hydroxynevirapine glucuronide GC-MS (3 TMS) - 70eV, Positivesplash10-0a4r-6484169000-c36eec21f7fe6bbc432b2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 2-Hydroxynevirapine glucuronide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 10V, Positive-QTOFsplash10-052f-0040900000-ae232306a8c13f74808f2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 20V, Positive-QTOFsplash10-00lr-0190000000-ba33355863d8c52c32112017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 40V, Positive-QTOFsplash10-00kf-6290000000-4d608cc9ada10bbc47582017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 10V, Negative-QTOFsplash10-08fr-2340900000-1a63677f82c040cb1b8f2017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 20V, Negative-QTOFsplash10-01su-5923500000-ace69787f4336f56caf12017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 40V, Negative-QTOFsplash10-001l-6390000000-406f775a2005ea7310502017-10-06Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 10V, Positive-QTOFsplash10-052f-0010900000-1e10dce16ab43c9eef752021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 20V, Positive-QTOFsplash10-0a5c-0016900000-bd959d38f64ece050e9f2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 40V, Positive-QTOFsplash10-001l-0090000000-6dda69ea3d603b86d2642021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 10V, Negative-QTOFsplash10-0a59-0090700000-d020d15f8d05cdd625682021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 20V, Negative-QTOFsplash10-001i-0090200000-94d347a105a86e6737832021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 2-Hydroxynevirapine glucuronide 40V, Negative-QTOFsplash10-001r-1091000000-6a5ffa1634e943fa05b32021-10-12Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-24Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Cytoplasm
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableNormal
      Not Available
details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound71316036
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available